Israel

SGX Research Series: 10 in 10

The Trendlines Group – from seed to market

"We believe that our company is undervalued by the market."
put on the active gear and start exploring places that will get your heart rate pumping - THE EDGE SINGAPORE

Zest

put on the active gear and start exploring places that will get your heart rate pumping

put on the active gear and start exploring places that will get your heart rate pumping
Weekout: North Miznon, Marks & Spencer, Make-A-Wish Foundation - THE EDGE SINGAPORE

Things to do

Weekout: North Miznon, Marks & Spencer, Make-A-Wish Foundation

This week: Sign up for a charity run, read a book on ethical eating, and savour healthy Israeli cuisine
In vaccine roll-out, Singapore is fastest in Asia Pacific but Israel is the global one to beat - THE EDGE SINGAPORE

Healthcare

In vaccine roll-out, Singapore is fastest in Asia Pacific but Israel is the global one to beat

As the modest vaccine rollout gets underway, economies may recover as herd immunity kicks in.
iX Biopharma secures Israel patent for WaferiX - THE EDGE SINGAPORE

Company in the news

iX Biopharma secures Israel patent for WaferiX

iX Biopharma says its intellectual property rights for its sublingual wafer technology is now secured in five continents.
Israel moves to find cure for coronavirus - THE EDGE SINGAPORE

Covid-19

Israel moves to find cure for coronavirus

"How do we stop [Covid-19] in its tracks?" asks Jon Medved, founder and CEO of OurCrowd.

Tech

Asiatravel partners Yaturu to introduce 'digital theatrical tours'

SINGAPORE (Mar 8): Asiatravel.com Holdings and its B2B division, TAcentre.com, say they are bringing Hollywood theatrics to tourism by introducing “digital theatrical tours” to its customers in partnership with Yaturu 5800 Israel.

M&A

SGX said to express interest in acquiring Tel Aviv Stock Exchange

SINGAPORE (Mar 1): The Singapore Exchange is said to be among a number of foreign stock exchanges to express an interest in acquiring a controlling share in Israel’s Tel Aviv Stock Exchange (TASE).

Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million inv

Trendlines Medical makes maiden investment in medical device startup

SINGAPORE (Oct 16): Trendlines Medical Singapore, a 76.43%-owned subsidiary of Catalist-listed Israeli company The Trendlines Group, has made its first investment by committing a total of US$60,000 ($81,150) to a medical device start-up, InterVaal.
×